Search

Your search keyword '"David C, Bloom"' showing total 145 results

Search Constraints

Start Over You searched for: Author "David C, Bloom" Remove constraint Author: "David C, Bloom"
145 results on '"David C, Bloom"'

Search Results

1. A Broad Influenza Vaccine Based on a Heat-Activated, Tissue-Restricted Replication-Competent Herpesvirus

2. Very Broadly Effective Hemagglutinin-Directed Influenza Vaccines with Anti-Herpetic Activity

Catalog

Books, media, physical & digital resources

3. Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2

4. A 77 Amino Acid Region in the N-Terminal Half of the HSV-1 E3 Ubiquitin Ligase ICP0 Contributes to Counteracting an Established Type 1 Interferon Response

5. Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides

6. The Impaired Neurodevelopment of Human Neural Rosettes in HSV-1-Infected Early Brain Organoids

7. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity

8. Deletion of the CTRL2 Insulator in HSV-1 Results in the Decreased Expression of Genes Involved in Axonal Transport and Attenuates Reactivation In Vivo

10. Herpes Simplex Viruses Whose Replication Can Be Deliberately Controlled as Candidate Vaccines

11. Development of the visual white matter pathways mediates development of electrophysiological responses in visual cortex

12. Variations in Aspects of Neural Precursor Cell Neurogenesis in a Human Model of HSV-1 Infection

13. Treatment of Infection and Inflammation Associated with COVID-19, Multi-Drug Resistant Pneumonia and Fungal Sinusitis by Nebulizing a Nanosilver Solution

14. Regulated protein expression for in vivo gene therapy for neurological disorders: Progress, strategies, and issues

15. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity

16. Evaluating the Reliability of Human Brain White Matter Tractometry

17. A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid Herpesvirus 3.

18. Reliable Detection of Herpes Simplex Virus Sequence Variation by High-Throughput Resequencing

19. Modeling Aβ42 Accumulation in Response to Herpes Simplex Virus 1 Infection: Two Dimensional or Three Dimensional?

20. Herpes Simplex Virus 1 MicroRNA miR-H8 Is Dispensable for Latency and Reactivation In Vivo

21. Correction for Zheng et al., 'Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells'

22. Human induced pluripotent stem cells for modeling of herpes simplex virus 1 infections

23. Contributors

24. Transneuronal tracing to map connectivity in injured and transplanted spinal networks

25. Antiviral activity of 1,4-disubstituted-1,2,3-triazoles against HSV-1 in vitro

26. Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells

27. Deletion of Herpes Simplex Virus 1 MicroRNAs miR-H1 and miR-H6 Impairs Reactivation

28. Herpes Simplex Virus 1 Strains 17 syn + and KOS(M) Differ Greatly in Their Ability To Reactivate from Human Neurons In Vitro

29. Herpes Simplex Virus 1 Strains 17

30. LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans.

31. R430: A potent inhibitor of DNA and RNA viruses

33. Virtual screening identified compounds that bind to cyclin dependent kinase 2 and prevent herpes simplex virus type 1 replication and reactivation in neurons

34. The CCCTC Binding Factor, CTRL2, Modulates Heterochromatin Deposition and the Establishment of Herpes Simplex Virus 1 Latency In Vivo

35. Perillyl alcohol and perillic acid exert efficient action upon HSV-1 maturation and release of infective virus

36. Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro

37. Peripheral AAV Injection for Retrograde Transduction of Dorsal Root and Trigeminal Ganglia

38. Personalized viral genomic investigation of herpes simplex virus 1 perinatal viremic transmission with dual fatality

39. In Vivo Knockdown of the Herpes Simplex Virus 1 Latency-Associated Transcript Reduces Reactivation from Latency

40. Depletion of the Insulator Protein CTCF Results in Herpes Simplex Virus 1 Reactivation In Vivo

41. Generation of three-dimensional human neuronal cultures: application to modeling CNS viral infections

42. Immunization by replication-competent controlled herpesvirus vectors

43. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication

44. Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time

45. Replication-Competent Controlled Herpes Simplex Virus

46. Herpes Simplex Virus Type-1: Replication, Latency, Reactivation and its Antiviral Targets

47. An Example of Synergy in Data Mobilization: the Arctos-VertNet Nexus

48. Development of Recombinant HSV-Based Vaccine Vectors

49. Why we need a centralized repository for isotopic data

50. HSV1 latent transcription and non-coding RNA: A critical retrospective